Have you already visited the College of Mages on Elk Island?🧙♀️
We highly recommend visiting this location, as it is linked to a global event running until July 29. Don't miss the chance to get unique gear, valuable resources and boosted EXP.⚔️
You can read more about the event on our Medium:
https://t.co/Nw27gItP3Y
#RPG #Event #PixelArt #NFT
Ronaldo dejó a los jugadores sin dinero
Una gran plataforma de mercados de predicción aceptaba jugadas sobre si Cristiano lloraría durante el Mundial. Tras la eliminación de Portugal, un video con sus emociones se viralizó por todo el fútbol X, y para parte de los jugadores todo parecía evidente, pero el pago nunca se realizó: surgió una disputa sobre si ese momento podía considerarse un llanto completo.
1win, en una situación similar, no quiso complicarse por un fotograma polémico y resolvió el asunto de forma más simple: calculó ambos resultados como ganadores para sus jugadores
Attention Biopharma stock pickers: $BBIO is set to graduate from the Russell 2000 to the Russell 1000 at the 26 June reconstitution.
Analysts see the move as a long-term positive that expands the stock's investable universe. Short term price fluctuations are not a reflection of fundamentals, and could be a good entry point for prospective investors.
#Biotech #BridgeBio
Pfizer's, $PFE, tafamidis franchise generated $6.3 billion in worldwide sales in 2025, making it one of the best-selling drugs on the planet. But a German court has now ordered Pfizer to stop using the phrase "near-complete stabilisation" to describe Vyndamax, finding the claim unsupported by the drug's own data.
That phrase sits at the heart of rival BridgeBio's, $BBIO, pitch for Attruby, the only drug whose approved label carries the designation.
Attruby's market share already sits north of 25%, and the ruling materially strengthens the differentiation case BridgeBio and its European partner Bayer have been building.
With Evercore analysts modelling peak Attruby sales approaching $5 billion, and Pfizer navigating simultaneous pressure on its patent position, the question of who owns the ATTR-CM market narrative is far from settled.
The German court ruling is a clear demonstration of the opportunities (and perils) facing investors in the pharmaceuticals market.
Looking for an Endorphina mirror?
Save the current Endorphina mirror so you always have quick access without unnecessary searching.We regularly update the links and make sure the current Endorphina mirror is always working and convenient to use.
https://t.co/QAKKdwW0Tx
If the main address is not opening, an Endorphina mirror will help.
We publish only the current Endorphina mirror so that access remains stable and convenient.
Bookmark this post so you do not have to search for working links again.
https://t.co/vi0QwYQGgt
A working Endorphina mirror is the easiest way to keep access in any situation.
We regularly update the current Endorphina mirror so you can get there quickly and without extra steps.
Everything you need is gathered in one place: current links
https://t.co/vi0QwYQGgt
Prediction markets are doing $6B a week in volume.
They're becoming a real financial infrastructure. But last year, a single whale gamed Polymarket's oracle and flipped a $7M contract from 9% to 100%. Just... because he could.
Prediction markets aren't broken because of bad ideas. They're broken because the services that power them don't coordinate. 🧵
Horizen’s mainnet is live on @Base. 🎉
A new chapter for onchain privacy begins today - bringing a seamless EVM-native environment designed for builders and users who want privacy that is practical, not complicated.
https://t.co/DOHPw1iOqh
#انترنت_غير_محدود_ياNTRA حملة انترنت غير محدود حملة سلمية ونضيفة وليس لها علاقة بالسياسة وليس لها جهة سيادية او سياسية ولا تستهدف احد سيوا تحقيق طلبها فقط وهو انترنت غير محدود
الاتنين الي عاملهم تاج هما سبب النت و الازمه الي احنا فيها. شركه احتكار للنت بالكامل و التانيه بتشارك بالي بتحصل و تغلي النت
حسبي الله ونعم الوكيل. بحسبن وانا عارف اصلا انهم شويه حراميه كفره لازم ضغط عشان ناخد حقنا
@NTRAEG@telecomegypt#انترنت_غير_محدود_ياNTRA